Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Perineural Clonidine as an Adjuvant With Ropivacaine for Popliteal Nerve Block in Patients Undergoing Foot and Ankle Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient undergoing foot or ankle surgery with popliteal nerve block planned for postoperative analgesia.~2. Adult, 19 years of age and older.~3. Subject classified as American Society of Anesthesiology (ASA) class 1, 2, or 3. The ASA defines these statuses as follows: 1-A normal healthy patient. 2-A patient with mild systemic disease. 3-A patient with severe systemic disease.~   -~Exclusion Criteria:~1. Any subject not classified as an ASA 1, 2, or 3.~2. Allergy/intolerance to local anesthetic, clonidine, and/or oxycodone.~3. Subject with a history of continuous opioid use for greater than one month prior to surgery.~4. Pre-existing neurologic deficit in lower extremity (surgical site).~5. Clinically significant coagulopathy (hemophilia, von Willebrand disease).~6. Patients who fail to follow the UAB Department of Anesthesiology Algorithm for the Preoperative Management of an Angiotensin Converting Enzyme Inhibitor (ACEI) or an Angiotensin Receptor Blocker (ARB). A copy of the algorithm can be found in Appendix 1. -

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clonidine and Ropivacaine (Type: EXPERIMENTAL): A bolus of 20 mL of 0.5% ropivacaine mixed with clonidine 1mcg/kg will be injected through the stimulating needle with gentle aspiration between divided doses (5 mL per dose).
- Ropivacaine (Type: ACTIVE_COMPARATOR): Standard saphenous nerve block (adductor canal approach) will be performed using 15ml of 0.5% ropivacaine

Based on this trial design, predict the completion outcome and termination type (if applicable).